Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (301-310 of 524) with videos related to

Pageof 53
Sort By:
Medicina (Kaunas, Lithuania)|February 25, 2022
Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDLJelena Vekic, Aleksandra Zeljkovic, Arrigo F G Cicero, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 11, 2018
Management of Statin Intolerance in 2018: Still More Questions Than AnswersPeter P Toth, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Inflammopharmacology|August 21, 2022
The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trialsSeyyed Mostafa Arabi, Mahla Chambari, Mahsa Malek-Ahmadi, et al.
Expert Opinion on Drug Safety|August 23, 2021
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanismYajnavalka Banerjee, Anca Pantea Stoian, José Silva-Nunes, et al.
Metabolism: Clinical and Experimental|October 18, 2023
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trialsPaschalis Karakasis, Dimitrios Patoulias, Konstantinos Pamporis, et al.
Giornale Italiano Di Cardiologia (2006)|April 20, 2016
[The extra-glycemic effects of liraglutide: focus on cardiometabolic markers]Rosaria Vincenza Giglio, Angelo Maria Patti, Dragana Nikolic, et al.
Current Pharmaceutical Design|June 21, 2022
Hypothyroidism and Risk of Cardiovascular DiseaseZoran M Gluvic, Sonja S Zafirovic, Milan M Obradovic, et al.
Medicina (Kaunas, Lithuania)|January 16, 2020
Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative ReviewValeriu Ardeleanu, Alexandra Toma, Kalliopi Pafili, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 21, 2005
Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up studyGiuseppe Coppola, Manfredi Rizzo, Maurizio G Abrignani, et al.
The Journal of Endocrinology|June 21, 2013
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseasesMilan Obradovic, Predrag Bjelogrlic, Manfredi Rizzo, et al.
Pageof 53

Showing results (301-310 of 524) with videos related to

Sort By:
Pageof 53
Medicina (Kaunas, Lithuania)|February 25, 2022
Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDLJelena Vekic, Aleksandra Zeljkovic, Arrigo F G Cicero, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 11, 2018
Management of Statin Intolerance in 2018: Still More Questions Than AnswersPeter P Toth, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Inflammopharmacology|August 21, 2022
The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trialsSeyyed Mostafa Arabi, Mahla Chambari, Mahsa Malek-Ahmadi, et al.
Expert Opinion on Drug Safety|August 23, 2021
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanismYajnavalka Banerjee, Anca Pantea Stoian, José Silva-Nunes, et al.
Metabolism: Clinical and Experimental|October 18, 2023
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trialsPaschalis Karakasis, Dimitrios Patoulias, Konstantinos Pamporis, et al.
Giornale Italiano Di Cardiologia (2006)|April 20, 2016
[The extra-glycemic effects of liraglutide: focus on cardiometabolic markers]Rosaria Vincenza Giglio, Angelo Maria Patti, Dragana Nikolic, et al.
Current Pharmaceutical Design|June 21, 2022
Hypothyroidism and Risk of Cardiovascular DiseaseZoran M Gluvic, Sonja S Zafirovic, Milan M Obradovic, et al.
Medicina (Kaunas, Lithuania)|January 16, 2020
Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative ReviewValeriu Ardeleanu, Alexandra Toma, Kalliopi Pafili, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|May 21, 2005
Fibrinogen as a predictor of mortality after acute myocardial infarction: a forty-two-month follow-up studyGiuseppe Coppola, Manfredi Rizzo, Maurizio G Abrignani, et al.
The Journal of Endocrinology|June 21, 2013
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseasesMilan Obradovic, Predrag Bjelogrlic, Manfredi Rizzo, et al.
Pageof 53